Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Prevention of Subclinical Atherosclerosis Progression, Prevention of Cognitive Decline
Interventions: Nattokinase, Placebo; Dietary Supplement · Other
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years to 100 Years
Enrollment: 265 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Aphasia, Cerebrovascular Stroke
Interventions: Transcranial Magnetic Stimulation, Repetitive; Device
Lead sponsor: Boston University; Other
Eligibility: 45 Years to 80 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2013
U.S. locations: 3
States / cities: Boston, Massachusetts • Philadelphia, Pennsylvania

Conditions: Endometriosis
Interventions: A whole food plant based diet; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Type 1 Diabetes Mellitus
Interventions: Tandem t:slim X2 with HCL or PLGS; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 65 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Orlando, Florida • Rochester, Minnesota • Syracuse, New York + 1 more

Conditions: Anxiety Disorders, Obsessive-Compulsive Disorder
Interventions: Parent Coached Exposure Therapy - Individualized, Cognitive Behavior Therapy, Parent Coached Exposure Therapy - Group (removed from study); Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 7 Years to 75 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cardiogenic Shock, Heart Failure, Inflammation
Interventions: Methylprednisone, Standard of Care (SOC); Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Panic Disorder
Interventions: Darigabat, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 31
States / cities: Phoenix, Arizona • Lafayette, California • Los Angeles, California + 27 more

Conditions: Niemann-Pick Disease, Type C
Interventions: Adrabetadex; Drug
Lead sponsor: Mandos LLC; Industry
Eligibility: 4 Years to 21 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 15
States / cities: Birmingham, Alabama • Orange, California • San Francisco, California + 12 more

Conditions: Stress
Interventions: HeartMath Resilience Program; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Suicide, Attempted, Suicidal Ideation Active
Interventions: Post Admission Cognitive Therapy (PACT); Behavioral
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 4
States / cities: Bethesda, Maryland • Durham, North Carolina • Fort Belvoir, Virginia

Conditions: Ventilated Patient in Intensive Care
Interventions: Weighted blanket, Standard hospital linens; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Thoracolumbar Spinal Fusions
Interventions: Saline, Ketorolac; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Southfield, Michigan

Conditions: Respiratory Distress Syndrome
Interventions: Lucinactant for Inhalation, nCPAP alone; Drug · Device
Lead sponsor: Windtree Therapeutics; Industry
Eligibility: 29 Weeks to 34 Weeks
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 11
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Loma Linda, California + 8 more

Conditions: Schizophrenia, Chronic Illness, Weight Gain, Psychotic Disorder
Interventions: Collaborative Chronic Illness Care Model; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 1,067 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 8
States / cities: Long Beach, California • West Los Angeles, California • Shreveport, Louisiana + 5 more

Conditions: Breast Cancer
Interventions: Dexmedetomidine, Liposomal bupivacaine; Drug
Lead sponsor: United States Naval Medical Center, Portsmouth; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Osteoarthritis, Knee
Interventions: CBD/CBN, CBD/THC, Placebo; Drug
Lead sponsor: Pure Green; Industry
Eligibility: 21 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: West Bloomfield, Michigan

Conditions: Treatment of Type I Diabetes Mellitus.
Interventions: Biological; Biological
Lead sponsor: DiaVacs, Inc.; Industry
Eligibility: 12 Years to 35 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: COVID-19, SARS-CoV 2
Interventions: Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine, Placebo for Azithromycin; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 11
States / cities: Birmingham, Alabama • San Diego, California • Torrance, California + 7 more

Conditions: Infertility
Interventions: EmbryoScope+; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Consumer Behavior, Consumer Preference
Interventions: front-of-package modification; Behavioral
Lead sponsor: Harvard School of Public Health (HSPH); Other
Eligibility: 18 Years and older
Enrollment: 5,028 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Temporomandibular Disorder (TMD)
Interventions: SPM Precursor-Enriched Marine Lipid Supplement, Medium-Chain Triglyceride Supplement; Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Lower Back Pain
Interventions: Pregnenolone, Placebo; Drug
Lead sponsor: Durham VA Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Headaches Associated With Subarachnoid Hemorrhage (SAH)
Interventions: Low dose fentanyl PCA, Standard IV fentanyl bolus; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Use Disorder (AUD)
Interventions: Recovery Navigator on an as needed basis up to 6 months, Recovery Navigator prior to hospital discharge, No interaction with Recovery Navigator; Behavioral · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Search by objective public record fields.

Nattokinase Atherothrombotic Prevention Study

Transcranial Magnetic Stimulation to Improve Speech in Aphasia

A Randomized Controlled Trial of a Nutritional Intervention for Endometriosis

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

A Trial of Parent-coached Exposure Therapy for Children With Anxiety Disorders and OCD

CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock

A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease

Heart Math Resilience Program on Jail Staff

Post Admission Cognitive Therapy (PACT) for the Inpatient Treatment of Military Personnel With Suicidal Behaviors

Weighted Blanket to Improve Sedation and Comfort During Ventilator Weaning

Ketorolac on Posterior Thoracolumbar Spinal Fusions

Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates

Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee

Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Randomized Trial Comparing EmbryoScope With EmbryoScope+.

Front-of-package Marketing on Fruit Drinks: Online RCT

Marine Lipids Ease Painful TMD

Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans

Randomized Trial for Pain Management in Low-grade Subarachnoid Hemorrhage

A Critical Illness Recovery Navigator for Alcohol